Videos

4:33

Erin Youngerberg noticed a small mole, the size of a pencil eraser, on her back. She was told not to worry. But it was stage IV melanoma, an aggressive form of skin cancer. Doctors went on to find tumors all over her body. This is her story.

Everyday Health is your No. 1 resource for health and wellness advice. We make it fun and easy to live a healthier, happier lifestyle. Subscribe now and start feeling better — every day.

SUBSCRIBE:
http://bit.ly/1LhozPy

VISIT EVERYDAYHEALTH.COM:
http://bit.ly/1taqdKn

FOLLOW US:
Facebook: http://on.fb.me/1o7gqo2
Twitter: http://bit.ly/1jx2ldL
Instagram: http://bit.ly/1Nj3Z0Q
Pinterest: http://bit.ly/1CNxcNO

1:28

Australian swimmer, Mack Horton took to Instagram to thank the person who encouraged him to get a mole checked out after seeing it during the Olympic Games.

11:36

Published on Sep 1, 2014

*NOTE*TUMOR DOCUMENTED FROM ONLY A 5 WEEKS TIME PERIOD-DID NOT LET GROW, WAS NOT A LONG TIME AS THIS HAPPENED FAST, WAS UNDER DR CARE ENTIRE TIME, SCC DID NOT FROM SUN EXPOSURE AND LACK OF SUN SCREEN BUT A GENETIC TRIGGER AND VIRUS.******TUMOR GREW IN ONLY 5 WEEKS TIME-EXTREMELY FAST AND AGGRESSIVE!

4:01

Published on Jun 8, 2015

Merkel Cell is an aggressive kind of skin cancer that has tripled in volume over the past several years. Want to know how you can protect your skin especially during these hot summer months? Radiation Oncologist Dr. Christopher Balamucki gives advice on how to keep your skin healthy, how to prevent skin cancer and what to look for if you're concerned.

2:11

Published on Jun 6, 2016

Dr. Paul Nghiem discusses his research at the ASCO 2016 meeting in Chicago.

5:55

Published Aug 2, 2016

Dr Kaufman speaks with ecancertv at ASCO 2016 to discuss the results of phase II JAVELIN Merkel 200 trial, in which patients with metastatic Merkl cell carcinoma received avelumab, a PD-L1 checkpoint inhibitor.

Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with Merkel cell polyomavirus, with limited therapeutic options after 1st-line chemotherapy.

Dr Kaufman describes the results of the JAVELIN trial in which, of a cohort of 88, six patients (9.8%) achieved complete responses, 12 (19.7%) had partial responses, and 7 (11.5%) had stable disease (83.3% responses were ongoing).

He also details the ongoing progression free survival data, and offers that additional clinical evaluation of avelumab for is warranted.

8:12
1:28

Create Cake Magic! Learn to make the cakes you've always dreamed of with online courses from CakeMade. http://bit.ly/1st0Roh Watch more How to Prevent Skin Cancer videos: http://www.howcast.com/videos/507157-How-to-Spot-Skin-Cancer-Skin-Cancer Learn about skin cancer from board-certified dermatologist Ahmet Altiner in this Howcast video. Skin cancer is abnormal proliferation of cells that make up the epidermis, the top layer of the skin. The majority of the cells are keratinocytes, but there are also melanocytes, merkel cells, and many other cells that make up the skin. When these cells grow disproportionate to what they should be growing, they form bumps and lumps, and some of the time, these can form a skin cancer. The majority of skin cancers we think about are grouped into two groups, melanoma, and non-melanoma. Melanoma is the most notorious one because it can cause severe mortality or morbidity, unlike non-melanoma skin cancers which are much more